Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Budd

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Stem Cells (Dayton, Ohio)|January 1, 1993
Interleukin-2: use in solid tumorsR M Bukowski, D McLain, T Olencki, et al.
Seminars in Oncology|May 29, 1999
Approaches to managing carboplatin-induced thrombocytopenia: focus on the role of amifostineG T Budd, R Ganapathi, L Wood, et al.
Cancer Research|January 15, 1994
Estrogen receptor mutations in tamoxifen-resistant breast cancerP S Karnik, S Kulkarni, X P Liu, et al.
Investigational New Drugs|January 1, 1986
Phase I trial of intraperitoneal chemotherapy with 5-fluorouracil and citrovorum factorG T Budd, M J Schreiber, E Steiger, et al.
Journal of Surgical Oncology|November 1, 1983
Treatment of advanced ovarian cancer with cisplatin, adriamycin, and cyclophosphamide: effect of treatment and incidence of intracranial metastasesG T Budd, K D Webster, R R Reimer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Phase-I trial of UltrapureTM human leukocyte interferon in human malignancyG T Budd, R M Bukowski, L Miketo, et al.
Investigational New Drugs|September 5, 2002
A phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinomaF Perez-Zincer, T Olencki, G T Budd, et al.
Clinical & Experimental Metastasis|September 23, 2009
MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissectionXueping Zhang, Amy Ladd, Ema Dragoescu, et al.
Investigational New Drugs|February 1, 1993
Phase II trial of doxorubicin and trifluoperazine in metastatic breast cancerG T Budd, R M Bukowski, A Lichtin, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2002
Phase I trial of capecitabine in combination with interferon alpha in patients with metastatic renal cancer: toxicity and pharmacokineticsD Z Chang, T Olencki, G T Budd, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Stem Cells (Dayton, Ohio)|January 1, 1993
Interleukin-2: use in solid tumorsR M Bukowski, D McLain, T Olencki, et al.
Seminars in Oncology|May 29, 1999
Approaches to managing carboplatin-induced thrombocytopenia: focus on the role of amifostineG T Budd, R Ganapathi, L Wood, et al.
Cancer Research|January 15, 1994
Estrogen receptor mutations in tamoxifen-resistant breast cancerP S Karnik, S Kulkarni, X P Liu, et al.
Investigational New Drugs|January 1, 1986
Phase I trial of intraperitoneal chemotherapy with 5-fluorouracil and citrovorum factorG T Budd, M J Schreiber, E Steiger, et al.
Journal of Surgical Oncology|November 1, 1983
Treatment of advanced ovarian cancer with cisplatin, adriamycin, and cyclophosphamide: effect of treatment and incidence of intracranial metastasesG T Budd, K D Webster, R R Reimer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Phase-I trial of UltrapureTM human leukocyte interferon in human malignancyG T Budd, R M Bukowski, L Miketo, et al.
Investigational New Drugs|September 5, 2002
A phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinomaF Perez-Zincer, T Olencki, G T Budd, et al.
Clinical & Experimental Metastasis|September 23, 2009
MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissectionXueping Zhang, Amy Ladd, Ema Dragoescu, et al.
Investigational New Drugs|February 1, 1993
Phase II trial of doxorubicin and trifluoperazine in metastatic breast cancerG T Budd, R M Bukowski, A Lichtin, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2002
Phase I trial of capecitabine in combination with interferon alpha in patients with metastatic renal cancer: toxicity and pharmacokineticsD Z Chang, T Olencki, G T Budd, et al.
Pageof 10